List of Intermune (company) patents

Patents where

Current Assignee

Name

Intermune (company)

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7407973 Use of pirfenidone in therapeutic regimens	Patent 7407973 was granted and assigned to Intermune (company) on August, 2008 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7407973	August 5, 2008
‌ US Patent 7491794 Macrocyclic compounds as inhibitors of viral replication	Patent 7491794 was granted and assigned to Intermune (company) on February, 2009 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7491794	February 17, 2009
‌ US Patent 7638488 Use of alpha-glucosidase inhibitors to treat alphavirus infections	Patent 7638488 was granted and assigned to Intermune (company) on December, 2009 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7638488	December 29, 2009
‌ US Patent 7728013 Method of modulating stress-activated protein kinase system	Patent 7728013 was granted and assigned to Intermune (company) on June, 2010 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7728013	June 1, 2010
‌ US Patent 7635707 Pirfenidone treatment for patients with atypical liver function	Patent 7635707 was granted and assigned to Intermune (company) on December, 2009 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7635707	December 22, 2009
‌ US Patent RE39821 Manufacture and expression of large structural genes	Patent RE39821 was granted and assigned to Intermune (company) on September, 2007 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	RE39821	September 4, 2007
‌ US Patent 8975235 Lysophosphatidic acid receptor antagonists	Patent 8975235 was granted and assigned to Intermune (company) on March, 2015 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	8975235	March 10, 2015
‌ US Patent 7566729 Modifying pirfenidone treatment for patients with atypical liver function	Patent 7566729 was granted and assigned to Intermune (company) on July, 2009 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7566729	July 28, 2009
‌ US Patent 10376497 Anti-fibrotic pyridinones	Patent 10376497 was granted and assigned to Intermune (company) on August, 2019 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	10376497	August 13, 2019
‌ US Patent 7816383 Methods of administering pirfenidone therapy	Patent 7816383 was granted and assigned to Intermune (company) on October, 2010 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7816383	October 19, 2010
‌ US Patent RE47142 Compounds and methods for treating inflammatory and fibrotic disorders	Patent RE47142 was granted and assigned to Intermune (company) on November, 2018 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	RE47142	November 27, 2018
‌ US Patent 9527816 Method of modulating stress-activated protein kinase system	Patent 9527816 was granted and assigned to Intermune (company) on December, 2016 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	9527816	December 27, 2016
‌ US Patent 7781474 Inhibitors of hepatitis C virus replication	Patent 7781474 was granted and assigned to Intermune (company) on August, 2010 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7781474	August 24, 2010
‌ US Patent 8048862 Macrocyclic inhibitors of hepatitis C virus replication	Patent 8048862 was granted and assigned to Intermune (company) on November, 2011 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	8048862	November 1, 2011
‌ US Patent 9675593 Anti-fibrotic pyridinones	Patent 9675593 was granted and assigned to Intermune (company) on June, 2017 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	9675593	June 13, 2017
‌ US Patent 10010536 Method of modulating stress-activated protein kinase system	Patent 10010536 was granted and assigned to Intermune (company) on July, 2018 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	10010536	July 3, 2018
‌ US Patent 9726677 Proteomic IPF markers	Patent 9726677 was granted and assigned to Intermune (company) on August, 2017 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	9726677	August 8, 2017
‌ US Patent 9017722 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone	Patent 9017722 was granted and assigned to Intermune (company) on April, 2015 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	9017722	April 28, 2015
‌ US Patent 7932267 Use of α-glucosidase inhibitors to treat alphavirus infections	Patent 7932267 was granted and assigned to Intermune (company) on April, 2011 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7932267	April 26, 2011
‌ US Patent 7767225 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients	Patent 7767225 was granted and assigned to Intermune (company) on August, 2010 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7767225	August 3, 2010
‌ US Patent 8648098 Pirfenidone therapy and inducers of cytochrome P450	Patent 8648098 was granted and assigned to Intermune (company) on February, 2014 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	8648098	February 11, 2014
‌ US Patent 7910610 Methods of administering pirfenidone therapy	Patent 7910610 was granted and assigned to Intermune (company) on March, 2011 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	7910610	March 22, 2011
‌ US Patent 8778947 Methods of administering pirfenidone therapy		Intermune (company)	Intermune (company)	United States Patent and Trademark Office	8778947	July 15, 2014
‌ US Patent 9561217 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone	Patent 9561217 was granted and assigned to Intermune (company) on February, 2017 by the United States Patent and Trademark Office.	Intermune (company)	Intermune (company)	United States Patent and Trademark Office	9561217	February 7, 2017
‌ US Patent 8013002 Methods of administering pirfenidone therapy	Patent 8013002 was granted and assigned to Intermune (company) on September, 2011 by the United States Patent and Trademark Office.		Intermune (company)	United States Patent and Trademark Office	8013002	September 6, 2011

Results per page:

50 results

0 selected

50 results

0 selected